CINECA IRIS Institutional Research Information System

PELLEGRINI, CAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2804
EU - Europa 1383
AS - Asia 334
AF - Africa 27
SA - Sud America 8
OC - Oceania 1
Totale 4557
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2761
IT - Italia 540
SE - Svezia 286
CN - Cina 179
BG - Bulgaria 160
DE - Germania 100
VN - Vietnam 89
AT - Austria 77
GB - Regno Unito 60
RU - Federazione Russa 56
CA - Canada 43
FR - Francia 29
IN - India 19
CI - Costa d'Avorio 17
FI - Finlandia 15
UA - Ucraina 15
BE - Belgio 13
PL - Polonia 12
TR - Turchia 12
JP - Giappone 10
KR - Corea 7
BR - Brasile 6
NG - Nigeria 6
PK - Pakistan 5
CH - Svizzera 4
ES - Italia 4
LB - Libano 3
NL - Olanda 3
RO - Romania 3
HK - Hong Kong 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
UG - Uganda 2
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
SG - Singapore 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4557
Salva come PNG Salva come JPEG
Città #
Fairfield 482
Woodbridge 329
Chandler 294
Houston 224
Ashburn 190
Seattle 187
Wilmington 169
Cambridge 164
Sofia 160
Serra 157
Ann Arbor 139
Beijing 85
Princeton 79
Lawrence 62
Vienna 60
Pisa 53
Bremen 50
Dong Ket 48
Medford 48
Des Moines 37
Ottawa 36
Rome 30
London 27
Dearborn 25
Nanjing 24
Redwood City 22
Pistoia 18
Abidjan 17
Frankfurt am Main 17
Marseille 15
San Diego 13
Brussels 12
Florence 11
Phoenix 10
Izmir 9
Livorno 9
Nanchang 9
Lancaster 8
Montecatini Terme 7
Changsha 6
Kunming 6
Lagos 6
Lucca 6
Redmond 6
Boardman 5
Milan 5
Norwalk 5
Padova 5
Tagliacozzo 5
Ancona 4
Apucarana 4
Ballabio 4
Boulder 4
Busto Arsizio 4
Guangzhou 4
Haikou 4
Hebei 4
Hefei 4
Jacksonville 4
Jiaxing 4
Toronto 4
Beirut 3
Dallas 3
Fremont 3
Kolkata 3
Massa 3
Parma 3
Seoul 3
Shenyang 3
Shenzhen 3
Tianjin 3
Wuhan 3
Żyrardów 3
Acquafredda 2
Auburn Hills 2
Bergen 2
Bursa 2
Cascina 2
Dalmine 2
Fort Worth 2
Gavardo 2
Harbin 2
Huéscar 2
Indiana 2
Kampala 2
Lanzhou 2
Magenta 2
Nagoya 2
Nichelino 2
Nürnberg 2
Paris 2
Pergine Valsugana 2
Porcari 2
Pordenone 2
Pullman 2
Rawalpindi 2
San Giuliano Terme 2
Sennori 2
Tokyo 2
Torre Del Lago Puccini 2
Totale 3529
Salva come PNG Salva come JPEG
Nome #
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 165
null 125
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 121
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 119
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 117
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 116
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 116
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 113
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 111
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 107
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 106
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 106
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 105
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 100
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation 100
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 97
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 97
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 95
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 94
null 94
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 92
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 86
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 85
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 85
P2X7 receptor-dependent tuning of gut epithelial responses to infection 81
Rifaximin Displays a Protective Activity in Experimental Enteropathy Induced by Indomethacin in Rats. 81
null 80
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 78
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 78
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 78
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 75
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 74
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 73
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy 73
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rat 70
Neuronal regulation of intestinal immune functions in health and disease 62
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 62
Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases 59
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis 57
Adenosine signaling in the tumor microenvironment 56
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence 53
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 52
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 52
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 52
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 50
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 49
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 48
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 45
Intestinal epithelial barrier and neuromuscular compartment in health and disease 44
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 43
The adenosine system at the crossroads of intestinal inflammation and neoplasia 41
- Medicament for preventing or treating irritable bowel syndrome or inflammatory bowel diseases 40
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 40
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 39
Donepezil improves vascular function in a mouse model of Alzheimer's disease 39
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 35
Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy 34
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation 34
NKG2A and COVID-19: another brick in the wall 31
Enteric glia at the crossroads between intestinal immune system and epithelial barrier: Implications for parkinson disease 29
From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease 29
Inflammatory Bowel Diseases: It's Time for the Adenosine System 28
Differential Impact of Weight Loss and Glycemic Control on Inflammasome Signaling 26
Editorial: IBD Management—Novel Targets and Therapeutic Perspectives 26
NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications 26
Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis. 25
Ectopic Lymphoid Organs and Immune-Mediated Diseases: Molecular Basis for Pharmacological Approaches 23
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 16
LRRK2 is reduced in Parkinson’s disease gut 15
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 13
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 10
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 8
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 7
null 6
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 4
The intestinal barrier in disorders of the central nervous system 3
Glomerular hyperfiltration in morbid obesity: Role of the inflammasome signalling 3
LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines 2
Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitis 1
Totale 4810
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018121 0000 00 00 25144042
2018/2019505 1420625 169 7634 1164127103
2019/20201149 90592695 120137 121105 1578911535
2020/2021765 61616732 4333 3153 10211939124
2021/2022760 27161825 146113 4136 624649181
2022/20231081 13316796103 122150 38127 145000
Totale 4810